Search

Your search keyword '"Lauring, Josh"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Lauring, Josh" Remove constraint Author: "Lauring, Josh" Database Complementary Index Remove constraint Database: Complementary Index
20 results on '"Lauring, Josh"'

Search Results

1. Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

2. Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.

3. Phase II Study of Taselisib in PIK3CA -Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.

4. PD48-02 FIRST SAFETY AND EFFICACY RESULTS OF THE TAR-210 ERDAFITINIB INTRAVESICAL DELIVERY SYSTEM IN PATIENTS WITH NON–MUSCLE-INVASIVE BLADDER CANCER WITH SELECT FGFR ALTERATIONS.

5. Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient Carcinoma.

6. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.

7. PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.

8. Using cancer genomics to guide clinical decisions.

9. HER2 missense mutations have distinct effects on oncogenic signaling and migration.

10. Engineering targeted chromosomal amplifications in human breast epithelial cells.

11. MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers.

12. Phase I Study of JNJ-74699157 in Patients with Advanced Solid Tumors Harboring the KRAS G12C Mutation.

14. Knockin of mutant PIK3CA activates multiple oncogenic pathways.

15. Tamoxifen-stimulated growth of breast cancer due to p21 loss.

19. TORn in Two Over Breast Cancer Drug Resistance.

20. The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.

Catalog

Books, media, physical & digital resources